Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses

BACKGROUND: Recommended regimens for HIV-positive individuals include the co-administration of dolutegravir (DTG) with two reverse transcriptase inhibitors (RTIs). Although rare, emerging resistance against DTG is often associated with the R263K substitution in integrase. In-vitro-selected R263K was...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Hanh T., Mesplède, Thibault, Wainberg, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851780/
https://www.ncbi.nlm.nih.gov/pubmed/27130466
http://dx.doi.org/10.1186/s12977-016-0265-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851780/
https://www.ncbi.nlm.nih.gov/pubmed/27130466
http://dx.doi.org/10.1186/s12977-016-0265-x

Ejemplares similares